# About nuupeptide — An Independent Longevity-Research Desk

> About nuupeptide: an independent literature digest on NAD+ and MOTS-c. How it reads the research, what it is not, and why the honest limits of the evidence are as important as the findings.

An independent, citation-anchored digest of the published science on cellular energy and longevity biology. Not a vendor. Not a clinic. Not medical advice.

## What nuupeptide is

nuupeptide is an independent editorial reference desk covering the published research on two molecules studied in the context of **longevity and cellular health**: NAD+ (Nicotinamide Adenine Dinucleotide) and MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c), with NAD+ as the lead. The site exists because this is a field where consumer interest outpaces the evidence by a large margin — where preclinical mouse data are routinely summarized as human health benefits, and where the genuine complexity of cellular aging gets reduced to a supplement recommendation.

This desk takes a different approach. Each page traces what was actually studied, in which species, with which methodology, and with explicit acknowledgment of where the evidence runs out. A 2025 *Nature Metabolism* review found that human clinical data on NAD+ precursor supplementation show limited efficacy and that tissue-specific NAD+ dynamics remain poorly characterized [1]. That conclusion is cited prominently here — not buried in a footnote — because it represents the authoritative current synthesis of a field that often prefers more optimistic framings.

MOTS-c is even earlier-stage: a fascinating molecule with compelling animal and mechanistic data and one observational human finding, and zero interventional human efficacy trials [9]. We cover it as what it is, not as what advocates sometimes claim it may be.

## Editorial method

Every factual claim on nuupeptide is tied to a numbered citation from the peer-reviewed literature — primary research articles, systematic reviews, or authoritative regulatory documents. The full source list is on the [references page](/references).

Several working principles govern how the literature is selected and summarized:

**Species is always stated.** A mouse finding is a mouse finding. A human finding is a human finding. The two are not interchangeable, and this desk never uses one to imply the other.

**Null and negative results are included.** If a study found no effect, or if a review concluded evidence is limited, that finding appears alongside positive findings — it is part of the record.

**Mechanism is distinguished from outcome.** Showing that a molecule activates AMPK (mechanism) is not the same as showing it prevents aging (outcome). This desk keeps those categories separate.

**Commercial context is noted.** When a field has significant commercial investment — as NAD+ supplementation emphatically does — that context shapes what gets studied and published. We note it where relevant and prioritize independent, peer-reviewed synthesis over single-lab claims.

**No updating lag.** The references include studies through 2025. Where a 2025 review supersedes an earlier finding, the 2025 review takes precedence in how findings are framed [1].

## What this desk is not

**Not a vendor.** nuupeptide does not sell any product, does not link to any supplement retailer, and receives no revenue from any supplement company or research-chemical supplier. There are no affiliate links.

**Not a clinic.** Nothing on this site is medical advice. No pages recommend that any person take, inject, or otherwise use any molecule described here. Where the page says "no dose is given," that is an editorial commitment, not a legal boilerplate.

**Not a practitioner directory.** No provider names, no clinic names, no referrals.

**Not a promise.** The field of longevity biology is genuinely exciting, and the research on NAD+ and MOTS-c has produced findings worth understanding carefully. But the distance from "interesting mouse study" to "proven human benefit" is long, and this desk exists in that distance — charting it honestly rather than eliding it.

Questions about research summarized here can be directed to the editorial address on the [contact page](/contact).

---

An independent literature digest on the cellular energy of aging — citations first, commerce last, conclusions honest.